Xu B, Sun T, Shi Y, Cui J, et al. Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study. Breast Cancer Res Treat 2022 Dec 2. doi: 10.1007/s10549-022-06785.
PMID: 36459284